야생동물 건강 시장 규모, 점유율 및 동향 분석 보고서 : 동물별, 제품별, 최종 용도별, 판매 채널별, 지역별 및 부문별 예측(2026-2033년)

Wildlife Health Market Summary

The global wildlife health market size was estimated at USD 2.7 billion in 2025 and is projected to reach USD 5.4 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. Some of the factors driving the market growth are rising zoonotic disease surveillance and One Health preparedness programs, government funding for avian influenza preparedness and wildlife protection and expansion of wildlife rehabilitation centers, zoos, and specialized veterinary infrastructure.

Increasing zoonotic disease outbreaks and cross-species transmission risks are driving higher investment in wildlife health surveillance, diagnostics, and preventive care. Governments and international organizations are expanding One Health frameworks linking animal, human, and environmental health, increasing demand for diagnostics, vaccines, and field treatment solutions across wildlife populations. For instance, in April 2026, World Organization for Animal Health stated that nearly 75% of emerging infectious diseases originate in animals, strengthening focus on wildlife disease monitoring and intervention. In addition, the 2026 UN High-Level Meeting on Pandemic Prevention prioritized animal health systems as frontline defenses against future pandemics, accelerating procurement of surveillance tools, veterinary pharmaceuticals, and disease response infrastructure across wildlife health programs.

Moreover, the rising H5 avian influenza preparedness spending is increasing adoption of vaccines, monitoring equipment, rescue consumables, and captive wildlife healthcare services. Wildlife facilities, national parks, and conservation centers are receiving targeted funding for surveillance, quarantine, and emergency response capacity. For instance, in April 2026, the Australian government committed USD 35.9 million to strengthen H5 bird flu preparedness planning, including wildlife surveillance, disease spread analysis, and protection of threatened species. Furthermore, more than USD 100 million was allocated nationally for H5 response preparedness, while 21 facilities received additional funding to protect 26 threatened species in captivity. These investments are expanding procurement across the market.

In addition, growth in zoological institutions, rehabilitation centers, and wildlife referral hospitals is increasing continuous demand for pharmaceuticals, anesthesia systems, monitoring devices, and specialized veterinary care. The captive facilities require routine disease management, emergency care, surgical intervention, and preventive vaccination programs for mammals, birds, reptiles, and aquatic species. For instance, in 2025-2026, multiple regions expanded wildlife hospital infrastructure to improve emergency response and specialized treatment capacity, particularly for threatened and rescued species. Furthermore, institutions are increasing procurement of critical care consumables, rescue equipment, and research tools for rehabilitation and conservation programs. This expansion of organized wildlife care facilities is creating sustained long-term demand across the market, particularly within captive facility end users.

Global Wildlife Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the wildlife health market report based on product, animal, end use, sales channel, and region.

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Mammals
• Birds
• Aquatic Species
• Reptiles
• Amphibians
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
  • Anti-infectives
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others
• Vaccines
• Diagnostics
  • Consumables, reagents and kits
  • Instruments and devices
• Equipment & Disposables
  • Critical Care Consumables
  • Anesthesia Equipment
  • Health Monitoring Equipment
  • Rescue & Resuscitation Equipment
  • Research Equipment
  • Others
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Captive Facilities
• Research Institutions
• Others
• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Direct Sales
• Distributors/GPO Sales
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. End Use
  • 1.2.4. Sales Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Bottom-Up Analysis
  • 1.7.3. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Zoonotic Disease Surveillance and One Health Preparedness Programs
    • 3.2.1.2. Government Funding for Avian Influenza Preparedness and Wildlife Protection
    • 3.2.1.3. Expansion of Wildlife Rehabilitation Centers, Zoos, and Specialized Veterinary Infrastructure
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Advanced Wildlife Diagnostics and Treatment Infrastructure
    • 3.2.2.2. Limited Veterinary Access and Regulatory Complexity in Free-Ranging Wildlife Care
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Pricing Analysis
• 3.4. Technology Landscape
• 3.5. Market Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTEL by SWOT Analysis

Chapter 4. Wildlife Health Market: By Animal Estimates & Trend Analysis

• 4.1. Wildlife Health Market, By Animal: Segment Dashboard
• 4.2. Wildlife Health Market, By Animal Movement Analysis
• 4.3. Wildlife Health Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 4.4. Mammals
  • 4.4.1. Mammals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Birds
  • 4.5.1. Birds Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Aquatic Species
  • 4.6.1. Aquatic Species Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Reptiles
  • 4.7.1. Reptiles Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Amphibians
  • 4.8.1. Amphibians Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Wildlife Health Market: By Product Estimates & Trend Analysis

• 5.1. Wildlife Health Market, By Product: Segment Dashboard
• 5.2. Wildlife Health Market, By Product Movement Analysis
• 5.3. Wildlife Health Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 5.4. Pharmaceuticals
  • 5.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Anti-infectives
    • 5.4.2.1. Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Parasiticides
    • 5.4.3.1. Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Analgesics
    • 5.4.4.1. Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Sedatives
    • 5.4.5.1. Sedatives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.6. Others
    • 5.4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Vaccines
  • 5.5.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Diagnostics
  • 5.6.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Consumables, Reagents and Kits
    • 5.6.2.1. Consumables, Reagents and Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Instruments and Devices
    • 5.6.3.1. Instruments and Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Equipment & Disposables
  • 5.7.1. Equipment & Disposables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Critical Care Consumables
    • 5.7.2.1. Critical Care Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Anesthesia Equipment
    • 5.7.3.1. Anesthesia Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. Health Monitoring Equipment
    • 5.7.4.1. Health Monitoring Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.5. Rescue & Resuscitation Equipment
    • 5.7.5.1. Rescue & Resuscitation Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.6. Research Equipment
    • 5.7.6.1. Research Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.7. Others
    • 5.7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Wildlife Health Market: By End Use Estimates & Trend Analysis

• 6.1. Wildlife Health Market, By End Use: Segment Dashboard
• 6.2. Wildlife Health Market, By End Use Movement Analysis
• 6.3. Wildlife Health Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 6.4. Captive Facilities
  • 6.4.1. Captive Facilities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Research Institutions
  • 6.5.1. Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Wildlife Health Market: By Sales Channel Estimates & Trend Analysis

• 7.1. Wildlife Health Market, By Sales Channel: Segment Dashboard
• 7.2. Wildlife Health Market, By Sales Channel Movement Analysis
• 7.3. Wildlife Health Market Estimates & Forecasts, by Sales Channel, 2021 to 2033 (USD Million)
• 7.4. Direct Sales
  • 7.4.1. Direct Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Distributors/GPO Sales
  • 7.5.1. Distributors/GPO Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Wildlife Health Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. Zoetis
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Boehringer Ingelheim International GmbH
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Tecnovax
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Jorgensen Laboratories.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. WEDGEWOOD PHARMACY
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Hallowell EMC
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. NexGen Pharmaceuticals.
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Virbac
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. IDEXX Laboratories
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Avian & Exotic Animal Clin Path Labs
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives